PET imaging with hypoxia tracers: a must in radiation therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT.Nuclear medicine communications · 2010
   Trial
2. Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review.Current oncology (Toronto, Ont.) · 2024
   Review
3. A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies.Cancers · 2022
   Review
4. Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).Radiation oncology (London, England) · 2011
   Article
5. Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.Molecular imaging and biology · 2011
   Review
6. Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.Proceedings of the National Academy of Sciences of the United States of America · 2011
   Article
7. Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging.Nuclear medicine and biology · 2011
   Article
8. Molecular imaging in cancer treatment.European journal of nuclear medicine and molecular imaging · 2011
   Review
9. Positron Emission Tomography Imaging of Hypoxia.PET clinics · 2009
   Article
10. [(68) Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia.Contrast media & molecular imaging
    Article

Corrections and comments

• Erratum issued
  Erratum to PET imaging with hypoxia tracers: a must in radiation therapy.2008
• Erratum issued

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as